Epsilon Healthcare Ltd (ASX: EPN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Epsilon Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $29.87 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 192.71 million
Earnings per share -0.049
Dividend per share N/A
Year To Date Return -34.04%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Epsilon Healthcare Ltd (ASX: EPN)
Latest News

EPN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Epsilon Healthcare Ltd

Formerly THC Global Group Limited (THC)

Hydroponics Company Ltd 

EPN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
22 Oct 2021 $0.16 $0.02 14.29% 433,481 $0.15 $0.16 $0.15
21 Oct 2021 $0.14 $0.02 16.00% 2,346,342 $0.13 $0.17 $0.13
20 Oct 2021 $0.13 $-0.01 -7.69% 233,408 $0.13 $0.14 $0.13
19 Oct 2021 $0.13 $-0.01 -7.14% 92,628 $0.14 $0.14 $0.13
18 Oct 2021 $0.14 $0.01 7.41% 97,886 $0.13 $0.14 $0.13
15 Oct 2021 $0.14 $0.02 16.67% 699,807 $0.13 $0.14 $0.12
14 Oct 2021 $0.12 $-0.01 -8.00% 100,000 $0.12 $0.12 $0.12
13 Oct 2021 $0.13 $0.02 18.18% 769,752 $0.12 $0.13 $0.11
12 Oct 2021 $0.11 $0.00 0.00% 280,643 $0.11 $0.11 $0.11
11 Oct 2021 $0.11 $-0.01 -8.70% 76,465 $0.11 $0.12 $0.11
08 Oct 2021 $0.12 $0.00 0.00% 79,465 $0.11 $0.12 $0.11
07 Oct 2021 $0.12 $0.00 0.00% 220,980 $0.12 $0.12 $0.11
06 Oct 2021 $0.12 $0.00 0.00% 239,494 $0.12 $0.12 $0.12
05 Oct 2021 $0.12 $0.00 0.00% 31,186 $0.12 $0.12 $0.12
04 Oct 2021 $0.12 $0.00 0.00% 82,032 $0.12 $0.12 $0.12
01 Oct 2021 $0.12 $0.00 0.00% 197,704 $0.12 $0.12 $0.12
30 Sep 2021 $0.12 $0.00 0.00% 108,327 $0.12 $0.13 $0.12
29 Sep 2021 $0.12 $-0.01 -8.00% 331,205 $0.13 $0.13 $0.12
28 Sep 2021 $0.13 $-0.01 -7.69% 60,451 $0.13 $0.13 $0.13
27 Sep 2021 $0.13 $-0.01 -7.41% 248,337 $0.13 $0.13 $0.13
24 Sep 2021 $0.14 $0.01 7.69% 40,433 $0.13 $0.14 $0.13

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Steven Xiaobo XU Non-Executive Director Jan 2018
Mr Xu is the Managing Director of Une-Innovation Consulting Australia Pty Ltd and Founding Partner of INP Capital Inc which manages a series of venture capital funds. The venture capital funds invest in companies specialised in Medical/Healthcare, AI, Fintech and Industrial technology and Medical Cannabis across Australia, New Zealand, North America and Israel. He has over 15 years experience working at PricewaterhouseCoopers and listed companies in Australia and China. He specialises in financing, IPO and M&A activities in a range of sectors. He is the Chairman of the Strategy and Management Committee (from 4 June 2019) and Risk Committee.
Mr Simon Francis Rowe Non-Executive Director Aug 2021
Mr Rowe is currently the Supply Chain Transformation & Operations Leader ANZ at Kimberly-Clark - a Fortune 500 personal care company. Prior to that, Simon has held associate director and senior manager level roles within KPMG and EY advisory focusing on operational transformation and optimization.
Dr Robert (Rob) Alexander Jenny Executive Director Aug 2021
Dr Jenny is currently an executive at Cannvalate - an Australian medicinal cannabis services company - where he manages their business development activities in the Australian and New Zealand market. Rob has previously held management and research roles including at Ensign Laboratories - one of Australia's contract pharmaceutical manufacturers - Immunoglobal Group, and Monash University.
Mr Jarrod Travers White Chief Executive Officer May 2020
-
Mr Sonny Didugu Joint Company SecretaryChief Operating Officer May 2020
-
Ms Louisa Ho Company Secretary Jun 2021
-
Jarrod Travers White Chief Executive Officer
-
Louisa Ho Company Secretary
-
Sonny Didugu Joint Company SecretaryChief Operating Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Barcoo Holdings Pty Ltd (Wyan Family Investments) 3,528,046 1.85%
BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 3,304,319 1.73%
Meta Growth Corp 2,942,489 1.54%
Health360 Investment Management Inc 2,698,334 1.42%
Barcoo Holdings Pty Ltd (Maple Ventures) 2,438,341 1.28%
Marcus Kelly Property Developments Pty Ltd 2,356,926 1.24%
Mcann Investments Pty Ltd 2,000,000 1.05%
Mr George Daaboul 2,000,000 1.05%
Citicorp Nominees Pty Limited 1,990,856 1.05%
Mrs Katja Gordon 1,865,000 0.98%
Agri Fibre Industries Pty Ltd 1,777,512 0.93%
Une-Innovation Consulting Australia Pty Ltd 1,587,302 0.83%
Pears Daisley Pty Ltd (Daisley Pears A/C) 1,500,000 0.79%
Mr Nicholas Charles Deverell Pownall 1,450,000 0.76%
Sawfam Pty Ltd (Sawyer Super Fund A/C) 1,409,751 0.74%
Bell Pro Investments Pty Limited 1,205,273 0.63%
Madonna Andrews (Andrews Family A/C) 1,023,810 0.54%
Mr Brian Thomas Clayton & Mrs Janet Clayton 1,000,000 0.53%
Superhero Nominees Pty Ltd 962,124 0.51%
HSBC Custody Nominees (Australia) Limited 925,800 0.49%

Profile

since

Note